$132.25
3.762.93%
Last update: Sep 15, 9:36 AM
Revvity Inc
RVTYNYSE
M&A: Human Cell Design (HCD) announced it will be acquired by Revvity (RVTY) on Wednesday, September 9, 2026
Revvity Earnings & Forecasts
Revvity (RVTY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Revvity Guidance
Revvity (RVTY) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $5.3 - $5.4, compared to a consensus EPS estimate of $5.25. Revvity also guided revenue in the range of $2.83B - $2.86B for the period.
Compared to prior guidance, Revvity raised its EPS outlook from a previous range of $5.2 - $5.3. On the revenue side, the company maintained its revenue forecast from a prior range of $2.81B - $2.84B.
Revvity has issued 17 guidance updates between August 1, 2023 and August 4, 2026. During this period, the company raised its outlook 7 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.22 | $1.02 | $1.58 | $1.14 |
| Actual | $1.41 | $1.06 | $1.70 | $1.18 |
| Surprise | +15.6% | +3.92% | +7.59% | +3.51% |
| Revenue | ||||
| Estimate | $703.6M | $704.4M | $766.6M | $699.7M |
| Actual | $729.7M | $711.1M | $772.1M | $698.9M |
| Surprise | +3.71% | +0.96% | +0.71% | -0.11% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.29 | $1.62 | $1.17 | $1.52 |
| Revenue | ||||
| Consensus | $696.2M | $762.1M | — | — |
